Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Menquadfi Generic Name & Formulations
Legal Class
Rx
General Description
Neisseria meningitidis polysaccharide antigens (conjugated to approx. 55mcg of tetanus toxoid protein carrier); 10mcg each of Group A, C, W, and Y; per 0.5mL; soln for IM inj; preservative-free.
Pharmacological Class
Meningitis vaccine.
How Supplied
Single-dose vials—5
Manufacturer
Generic Availability
NO
Menquadfi Indications
Indications
Meningitis immunization.
Menquadfi Dosage and Administration
Adults and Children
<2yrs: not established. Give by IM inj only. Primary vaccination: ≥2yrs: 0.5mL once as single inj. Booster vaccination: ≥15yrs: may give a single (0.5mL) dose for those at continued risk, if at least 4yrs have elapsed since the prior dose.
Menquadfi Contraindications
Contraindications
Severe allergic reaction after a previous dose of MenQuadfi or any other tetanus toxoid-containing vaccine.
Menquadfi Boxed Warnings
Not Applicable
Menquadfi Warnings/Precautions
Warnings/Precautions
Not for the prevention of N. meningitidis serogroup B disease. Not a substitute for routine tetanus immunization. Have epinephrine inj (1:1000) available. History of Guillain-Barre syndrome. Immunosuppressed. Complement deficiency. Eculizumab therapy. Risk of syncope. Pregnancy. Nursing mothers.
Menquadfi Pharmacokinetics
See Literature
Menquadfi Interactions
Interactions
Immunosuppressants may get suboptimal response. Concomitant other vaccines: see full labeling.
Menquadfi Adverse Reactions
Adverse Reactions
Inj site reactions (pain, erythema, swelling), myalgia, headache, malaise.
Menquadfi Clinical Trials
See Literature
Menquadfi Note
Notes
To enroll pregnant patients or obtain information call (800) 822-2463.
Menquadfi Patient Counseling
See Literature
Images
